PHD vs. Ozempic: Which Is Right for You?

GLP-1 medications like Ozempic are genuinely effective for many people. That's not in dispute. The honest question is which tool matches your biology, your goals, and your willingness to rebuild the metabolism underneath.

We're not going to spend this page bashing Ozempic. GLP-1s are one of the most consequential pharmacologic advances in obesity medicine in a generation. For a specific set of people, they are the right tool.

But choosing between "a clinical metabolic program" and "a GLP-1 prescription" is not the same choice. They do different things, they cost different money, and they leave you in very different places when they end. This page lays that out plainly.

Head-to-head

PHD vs. Ozempic, the honest table.

Honest, cited comparison of PHD Weight Loss and Ozempic (semaglutide).
	PHD Weight Loss	Ozempic (semaglutide)
Mechanism	Metabolic rebuild, reduce stress load, restore muscle, improve insulin sensitivity.	GLP-1 receptor agonism, appetite suppression and slowed gastric emptying.
Typical results framing	Sustained fat loss with muscle preserved, alongside improvements in energy, sleep, and metabolic markers over a 3-phase program.	Meaningful weight loss during active treatment, well-documented in the STEP clinical trial program.
Muscle impact	Muscle preservation is a core design principle: RD-set protein targets and progressive strength training are required.	Studies indicate a substantial share of GLP-1 weight loss can be lean mass, placeholder for the specific cited figure (typical trial reports cluster around ~25–40% depending on methodology).
What happens when you stop	Phase 3 is a designed maintenance phase, the metabolism you rebuilt is what holds the results.	STEP-1 trial extension: participants regained roughly two-thirds of lost weight within a year of stopping semaglutide.
Cost structure	$199/month (originally $399), all-inclusive, time-bound program, with a 30 day money-back guarantee.	Approximately $650–$1,100+/month out-of-pocket for the medication when uncovered by insurance, plus prescribing-clinician fees.
Supervision model	Weekly live group coaching plus clinical oversight for the full program and any taper.	Varies widely, from robust clinical follow-up to minimal telehealth touchpoints.
Who it's right for	People who want durable metabolic change, are willing to eat and train differently, and want to leave the program self-sufficient.	People with a clinical indication for GLP-1 therapy who accept ongoing medication use or a supervised eventual off-ramp.

Citations forthcoming: STEP-1 extension (Wilding et al., Diabetes, Obesity and Metabolism, 2022) for regain; body-composition analyses of GLP-1 therapy for lean-mass share; retail pricing surveys for out-of-pocket cost. DOI-linked references on next content pass.

Different tools, different problems

Two different paths.

A GLP-1 is a pharmacologic tool that suppresses appetite. PHD is a clinical program that rebuilds metabolism. They're solving different problems on different timelines.

PHD does not prescribe GLP-1s. If you and your physician decide medication is the right next step, that care happens with a prescribing clinician. If you want to rebuild the metabolism underneath, with or without ever using a medication, that's what PHD is built for.

FAQ

The real questions.

Does Ozempic work?

Yes, during active treatment. Clinical trials demonstrate meaningful weight loss on semaglutide. The honest caveat is what happens when the medication ends: the published extension of the STEP-1 trial shows most of that loss returning within a year without a rebuilt metabolism underneath.

Is PHD anti-medication?

No. GLP-1s are a legitimate tool for people who need them. PHD is simply not a prescribing service, we're a natural-first metabolic program. We're anti-only-medication, because a prescription without a program is a subscription, not a solution.

Which will keep my results?

A rebuilt metabolism is what keeps the results, not the last dose you took. That's the difference in design. PHD's Phase 3 is built specifically to make maintenance real; the medication, on its own, is not designed for that.

What about muscle loss on Ozempic?

Body-composition data on GLP-1 therapy consistently shows a meaningful share of the weight lost is lean mass, particularly when protein intake and strength training aren't structured around the medication. PHD's protocol is designed to prevent that.

Which is cheaper?

PHD is $199/month, originally $399/month, all-inclusive, with a 30 day money-back guarantee. Out-of-pocket Ozempic without insurance coverage typically runs several times that per month, before any clinician fees. Insurance coverage shifts the math substantially and varies by plan.

Bottom line

Ozempic is a tool. PHD is a program. Sometimes the answer is one; sometimes the answer is both, supervised and time-bound.

The wrong answer is a prescription with no plan attached to it.

Get an honest read on which fits you.

Two minutes. Your result includes a clear read on whether PHD's natural-first path is the fit for your biology.

Start Weight Loss 360

$199/month, originally $399/month. 30 day money-back guarantee.

Medical disclaimer: educational content, not medical advice. Do not start or stop any prescription medication without consulting a licensed clinician. Individual results vary.